tetano
Editor, Senior Moderator
Hum Vaccin Immunother. 2020 May 13:1. doi: 10.1080/21645515.2020.1758534. [Epub ahead of print]
The pulmonary-proteoliposome as a new therapeutic approach for Coronaviruses.
Feliciello I[SUP]1[/SUP], Procino A[SUP]1[/SUP].
Author information
Abstract
We are proposing? the use of pulmonary-proteoliposome as a new therapeutic approach for Coronaviruses. The designed strategy represents a potential treatment to reduce the overall viral load in the lungs and to help the immune system to successfully stave off the infection.
KEYWORDS:
Coronavirus; SARS-COV-2; liposome
PMID:32401611DOI:10.1080/21645515.2020.1758534
The pulmonary-proteoliposome as a new therapeutic approach for Coronaviruses.
Feliciello I[SUP]1[/SUP], Procino A[SUP]1[/SUP].
Author information
Abstract
We are proposing? the use of pulmonary-proteoliposome as a new therapeutic approach for Coronaviruses. The designed strategy represents a potential treatment to reduce the overall viral load in the lungs and to help the immune system to successfully stave off the infection.
KEYWORDS:
Coronavirus; SARS-COV-2; liposome
PMID:32401611DOI:10.1080/21645515.2020.1758534